English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A class of diacylglycerol acyltransferase 1 inhibitors identified by a combination of phenotypic high-throughput screening, genomics, and genetics.

MPS-Authors
/persons/resource/persons197532

Tschapalda,  K.
Department of Molecular Developmental Biology, MPI for Biophysical Chemistry, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

2321177.pdf
(Publisher version), 3MB

Supplementary Material (public)

2321177_Suppl_1.pdf
(Supplementary material), 8MB

2321177_Suppl_2.xlsx
(Supplementary material), 4MB

2321177_Suppl_3.xlsx
(Supplementary material), 179KB

2321177_Suppl_4.xlsx
(Supplementary material), 179KB

2321177_Suppl_5.xlsx
(Supplementary material), 208KB

2321177_Suppl_6.xlsx
(Supplementary material), 57KB

2321177_Suppl_7.docx
(Supplementary material), 207KB

Citation

Tschapalda, K., Zhang, Y. Q., Liu, L., Golovnina, K., Schlemper, T., Eichmann, T. O., et al. (2016). A class of diacylglycerol acyltransferase 1 inhibitors identified by a combination of phenotypic high-throughput screening, genomics, and genetics. EBioMedicine, 8, 49-59. doi:10.1016/j.ebiom.2016.04.014.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-0E2A-2
Abstract
Excess lipid storage is an epidemic problemin human populations. Thus, the identification of small molecules to treat or prevent lipid storage-related metabolic complications is of great interest. Here we screened >320.000 compounds for their ability to prevent a cellular lipid accumulation phenotype. We used fly cells because the multifarious tools available for this organism should facilitate unraveling the mechanism-of-action of active small molecules. Of the several hundred lipid storage inhibitors identified in the primary screen we concentrated on three structurally diverse and potent compound classes active in cells of multiple species (including human) and negligible cytotoxicity. Together with Drosophila in vivo epistasis experiments, RNA-Seq expression profiles suggested that the target of one of the small molecules was diacylglycerol acyltransferase 1 (DGAT1), a key enzyme in the production of triacylglycerols and prominent human drug target. We confirmed this prediction by biochemical and enzymatic activity tests.